BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38401884)

  • 21. [Protein O-GlcNAcylation and regulation of cell signalling: involvement in pathophysiology].
    Issad T; Pagesy P
    Biol Aujourdhui; 2014; 208(2):109-17. PubMed ID: 25190571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological and pathological evidence of O-GlcNAcylation regulation during pregnancy related process.
    de Lima Castro M; Dos Passos RR; Justina VD; do Amaral WN; Giachini FR
    Placenta; 2023 Sep; 141():43-50. PubMed ID: 37210277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Undetectable histone O-GlcNAcylation in mammalian cells.
    Gagnon J; Daou S; Zamorano N; Iannantuono NV; Hammond-Martel I; Mashtalir N; Bonneil E; Wurtele H; Thibault P; Affar el B
    Epigenetics; 2015; 10(8):677-91. PubMed ID: 26075789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Beginner's Guide to
    Mannino MP; Hart GW
    Front Immunol; 2022; 13():828648. PubMed ID: 35173739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
    Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
    Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
    Sermikli BP; Aydogdu G; Yilmaz E
    Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Protein O-GlcNAcylation Using Bifunctional Small Molecules.
    Ma B; Khan KS; Xu T; Xeque Amada J; Guo Z; Huang Y; Yan Y; Lam H; Cheng AS; Ng BW
    J Am Chem Soc; 2024 Apr; 146(14):9779-9789. PubMed ID: 38561350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O-GlcNAcylation, a sweet link to the pathology of diseases.
    Nie H; Yi W
    J Zhejiang Univ Sci B; 2019 May; 20(5):437-448. PubMed ID: 31090269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of O-GlcNAcylation Regulates Autophagy in Cortical Astrocytes.
    Rahman MA; Hwang H; Cho Y; Rhim H
    Oxid Med Cell Longev; 2019; 2019():6279313. PubMed ID: 31827688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of O-GlcNAcylation in Immune Cell Activation.
    Qiang A; Slawson C; Fields PE
    Front Endocrinol (Lausanne); 2021; 12():596617. PubMed ID: 33986724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
    Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
    PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.
    Collins HE; Chatham JC
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165712. PubMed ID: 32014551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
    Nagel AK; Ball LE
    Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Zhang Z; Parker MP; Graw S; Novikova LV; Fedosyuk H; Fontes JD; Koestler DC; Peterson KR; Slawson C
    J Biol Chem; 2019 Jan; 294(4):1363-1379. PubMed ID: 30523150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
    Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
    Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
    Xu C; Liu G; Liu X; Wang F
    Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yeast cells as an assay system for in vivo O-GlcNAc modification.
    Nakanishi H; Li F; Han B; Arai S; Gao XD
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway.
    Ferrer CM; Lynch TP; Sodi VL; Falcone JN; Schwab LP; Peacock DL; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cell; 2014 Jun; 54(5):820-31. PubMed ID: 24857547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein O-GlcNAcylation: emerging mechanisms and functions.
    Yang X; Qian K
    Nat Rev Mol Cell Biol; 2017 Jul; 18(7):452-465. PubMed ID: 28488703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.